ABSTRACT Stimulation of horse platelets with platelet-activating factor (PAF) induces a rapid degradation of phosphatidylinositol 4,5-bisphosphate [Ptdlns(4,5)P2j. Addition of 0.1 JM PAF for 5 sec to platelets prelabeled with 32P induces a 50% loss of [32P]Ptdlns(4,5)P2. 32P-Labeled phosphatidylinositol 4-monophosphate (PtdIns4P) and [32P]phosphatidylinositol (PtdIns) also are decreased, albeit at a slower rate. Loss Of 32P radioactivity correlates with a net loss of fatty acids from both polyphosphoinositides. Stimulation of platelets with PAF also produces formation of [32P]phosphatidic acid and [32P]lysophosphatidylinositol. The initial disappearance of inositol lipids is subsequently followed by resynthesis, as evidenced by increased incorporation of 32p into Ptdlns(4,5)P2, PtdIns4P, and PtdIns. The resynthesis of the inositides increases with time and is proportional to the concentration of PAF. Prostacyclin (1 ,uM) inhibits (i) the formation of phosphatidic acid and lysophosphatidylinositol and (ii) the resynthesis of polyphosphoinositides induced by 0.03 ,uM PAF without affecting the initial loss of Ptdlns(4,5)P2. The loss of inositol lipids appears to be a primary event of platelet activation. The initial loss of polyphosphoinositides might be linked to the initiation of cellular activation by mobilizing membrane-bound Ca2+, whereas the subsequent formation of these lipids might be involved in mechanisms to prevent overstimulation of the cell.
for 5 sec to platelets prelabeled with 32P induces a 50% loss of [32P]Ptdlns(4,5)P2. 32P-Labeled phosphatidylinositol 4-monophosphate (PtdIns4P) and [32P] phosphatidylinositol (PtdIns) also are decreased, albeit at a slower rate. Loss Of 32P radioactivity correlates with a net loss of fatty acids from both polyphosphoinositides. Stimulation of platelets with PAF also produces formation of [32P]phosphatidic acid and [32P]lysophosphatidylinositol. The initial disappearance of inositol lipids is subsequently followed by resynthesis, as evidenced by increased incorporation of 32p into Ptdlns(4,5)P2, PtdIns4P, and PtdIns. The resynthesis of the inositides increases with time and is proportional to the concentration of PAF. Prostacyclin (1 ,uM) inhibits (i) the formation of phosphatidic acid and lysophosphatidylinositol and (ii) the resynthesis of polyphosphoinositides induced by 0.03 ,uM PAF without affecting the initial loss of Ptdlns(4,5)P2. The loss of inositol lipids appears to be a primary event of platelet activation. The initial loss of polyphosphoinositides might be linked to the initiation of cellular activation by mobilizing membrane-bound Ca2+, whereas the subsequent formation of these lipids might be involved in mechanisms to prevent overstimulation of the cell.
Platelet-activating factor (PAF), a phospholipid mediator of anaphylaxis (1) , is released from leucocytes after immunologic and nonimmunologic stimulation (2) . The structure of this compound has been elucidated as 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (3, 4) . PAF induces hypotension (5, 6) , neutropenia, and thrombocytopenia in vivo (7, 8) ; in vitro, PAF promotes chemotaxis and degranulation in neutrophils (9) (10) (11) and induces shape change, release of granule content, and aggregation in platelets (12) (13) (14) (15) (16) .
The biochemical mechanisms by which PAF elicits physiological responses are not fully understood. In platelets, PAF has been shown to stimulate the phosphatidylinositol (PtdIns) cycle (16, 17) , release of arachidonic acid from membrane phospholipids (16, 18) , and the phosphorylation of specific proteins (10) . These biochemical responses are induced also by other platelet stimuli such as ADP, thrombin, or ionophore A23187 (19) (20) (21) and are thought to be the consequence of the release of Ca2" from a cellular pool inaccessible to chelating agents (20, 22, 23) . Direct studies suggest that PAF induces a rapid mobilization of Ca2" in platelets (24) .
Recently, we have observed a rapid loss of phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P2] in thrombin-stimulated horse The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact.
platelets (25) . Because PtdIns(4,5)P2 might provide Ca2+-binding sites in the plasma membrane (26) (27) (28) , it has been suggested that the rapid loss of this phospholipid might be a mechanism by which the initial release of Ca2+ could be achieved (25) . We now show that PAF also causes a rapid but transient decrease in PtdIns(4,5)P2, phosphatidylinositol 4-monophosphate (PtdIns4P), and PtdIns in the absence of extracellular Ca2. This initial decrease is followed by resynthesis of the inositides.
MATERIALS AND METHODS
Platelet-activating factor, 1-O-alkyl(C16+C18)-2-acetyl-3-phosphorylcholine glycerol (PAF), was obtained from CalbiochemBehring; lyso-PAF (IPAF), 1-O-alkyl-3-phosphorylcholine glycerol, was kindly provided by J. Benveniste, Clamart, France. All other reagents were obtained as described (16, 25) .
Platelet suspensions were prepared and labeled with [32p]-orthophosphate as described (25) . Platelet-rich plasma from 500 ml of horse blood collected with anticoagulant buffer containing 1.3% citric acid, 2.5% sodium citrate, and 2% dextrose was prepared by centrifugation at 300 X g for 15 min. Platelets were then separated by centrifugation at 3,000 X g for 20 min and resuspended in 20 ml of Hepes/saline buffer (25 mM Hepes, pH 7.2/125 mM NaCl/10 mM glucose/i mM EGTA, pH 7.2).
After addition of 2 mCi (1 Ci = 3.7 x 1010 Bq) of carrier-free [32P]orthophosphate (100 ,tCi/ml), the platelet suspension was incubated at 37°C for 90 min. Platelets labeled with 32p were then washed twice with 100 ml of Hepes/saline and resuspended in the same buffer at a platelet concentration of 109 cells per ml. It should be noted that the Hepes/saline buffer used throughout these experiments always contained 1 mM EGTA and no added Ca2 . Under these conditions (and without stirring), addition of PAF did not cause platelet aggregation. PAF was dissolved in Hepes/saline containing 0.3% bovine serum albumin. Triplicate samples of platelet suspension (0.5 ml; 5 x 108 cells) were incubated with various concentrations of PAF for 10 sec or with 0.1 ,uM PAF for different times; then reactions were stopped and lipids were extracted and separated as before (16, 25) . In some experiments, cells were pretreated with prostacyclin (1 ,tM) for 2-4 min before the addition of PAF (0.1 or 0.03 uM). All experiments, unless otherwise mentioned, represent one of at least four that gave closely similar results.
Abbreviations: PAF, platelet-activating factor; 1PAF, lyso-PAF; PtdIns, phosphatidylinositol; PtdIns4P, phosphatidylinositol 4-monophosphate; PtdIns (4, 5) The fatty acid composition of PtdIns4P and Ptdlns(4,5)P2 was determined by gas-liquid chromatography. PtdIns4P and PtdIns(4,5)P2 were extracted from 32P-labeled platelets, separated by one-dimensional thin-layer chromatography (25) , localized by a very brief period (2-3 min) of autoradiography, and hydrolyzed overnight at 40'C with 1.6 ml of methanol and 0.4 ml of 1 M NaOH. Then the pH was brought to 2 by adding formic acid, and the fatty acids were extracted three times with 6 ml of hexane. The hexane was evaporated under N2, and the methyl esters of fatty acids were prepared by adding diazomethane in ether. Samples were analyzed with a 560 Tracor gas chromatograph lTracor Analytical Instruments, Austin, TX) equipped with a column (1,800 X 2 mm) packed with SP2330 on 100/120 Supelcoport. N2 flow rate was 30 or 20 ml/min, and the temperature was either at 1660C or 200'C, respectively. RESULTS Fig. 1 30) also were produced. This indicates that PAF induces activation of both phospholipases C and A2. IPAF (0. 1 jxM), which lacks the acetate group in the 2-position and the biological potency, did not induce lipid changes (Fig. 1) .
The fatty acid analysis of PtdIns4P and PtdIns(4,5)P2 showed that 0.1 ,uM PAF for 10 sec induced a net loss of all fatty acids of these lipids (Table 1 ). This observation supports our previous conclusion (25) Table 1) . Ptdlns(4,5)P2 loss was maximally induced 5 sec after addition of 0.1 /LM PAF, whereas maximal loss of PtdIns4P and PtdIns occurred at 10 sec (Fig. 2) . Furthermore, the initial losses of inositol lipids were subsequently followed by their resynthesis, as evidenced by increased incorporation of 32p into these lipids. Resynthesis of Ptdlns(4,5)P2 preceded that of PtdIns or PtdIns4P. (Fig. 4) . Under these conditions, the Ca2"-dependent formation of PtdOH and lPtdIns (21, 29, 30 ) also was substantially reduced (Fig. 4) . Thus, it appears that the initial loss of PtdIns(4,5)P2 is independent of intracellular mobilization of Ca2+, whereas its resynthesis is a Ca2+-regulated process. This interpretation is further supported by the observation that the Ca2+ ionophore A23187, which mobilizes Ca2+, induced the synthesis of PtdIns(4,5)P2 without producing the initial loss (25) .
DISCUSSION
Our present results indicate that PAF induces two distinct changes in inositol lipid metabolism: an initial decrease and subsequent resynthesis. The changes in PtdIns(4,5)P2 precede those in PtdIns4P and Ptdlns. The loss of PtdIns(4,5)P2 occurs very early during stimulation and is sensitive to relatively low concentrations of PAF. Furthermore, this early loss of Ptdlns(4,5)P2, induced by low concentrations of PAF, is the only lipid change not affected by prostacyclin. These observations suggest that the loss of Ptdlns(4,5)P2 is a primary event during platelet stimulation and independent of mobilization of cytoplasmic Ca2+. The PtdIns(4,5)P2 resynthesis, on the other hand, appears later on, and is secondary to the mobilization of internal platelet Ca2'.
PAF also generates PtdOH and IPtdlns, indicating that PtdIns is degraded by both phospholipase C and phospholipase A2 activities. These metabolic changes induced by PAF are qualitatively similar to those observed in thrombin-stimulated platelets (25) . The enzymatic basis for the stimulus-coupled loss of polyphosphoinositides is not yet clear; the relative importance of Ptdlns and PtdIns4P kinases, polyphosphoinositide phosphatases, and phosphodiesterases has been discussed (25) . However, recent information (31) indicates that PtdIns(4,5)P2 is degraded by phosphodiesteratic cleavage in thrombin-stimulated platelets.
PAF elicits physiological responses by increasing the intracellular concentration of Ca2+ (24) . But, unlike PtdOH, it exhibits no ionophoretic properties in intact lipid bilayers (32) . Moreover, recent binding studies indicate the presence of platelet receptors for PAF (33) . All this information might suggest that Ca2' mobilization in PAF-stimulated platelets is somehow linked to certain early biochemical changes occurring upon receptor activation. One such biochemical change could be the degradation of inositol phospholipids, especially that of Ptdlns(4,5)P2. These lipids located at the cytoplasmic face of the plasma membrane can provide important cellular Ca2+-binding sites (25) (26) (27) (28) and also might be required for the operation of Ca2+-ATPase (34) . Therefore, upon degradation of these lipids, the mem- brane-bound Ca2+ can be released in the cytosol and activate various Ca2'-dependent enzymes such as phospholipases (16) (17) (18) (19) (20) (21) and protein kinases (19) . The formation of 1,2-diacylgylcerol that might be produced by phosphodiesteratic degradation of PtdIns(4,5)P2 also could play an important role in transmembrane signaling by stimulation of protein kinase C (35) .
The possible role for polyphosphoinositides in Ca2+ mobilization is supported by several lines of evidence. (i) The loss of inositol lipids, especially that of PtdIns(4,5)P2, is a very early event (Fig. 2) and appears to be mediated by receptor activation (25) . (ii) This response is induced by other platelet agonists such as thrombin (25) and ADP (unpublished data), which are known to mobilize intraplatelet Ca2+, and yet this effect itself appears to be insensitive to Ca2+. (iii) A similar receptor-mediated loss of Ptdlns(4,5)P2 has been observed after hormonal stimulation of hepatocytes (36) and parotid acinar cells (37) , and it appears to be independent of Ca2+ mobilization (36, 37) .
Formation of PtdOH is a consequence of activation of PtdInsspecific phospholipase C, a Ca2+-dependent enzyme (16, 20, 29) . The loss of Ptdlns(4,5)P2 is independent of Ca2' mobilization and might precede and trigger the degradation of PtdIns and the subsequent formation of PtdOH (16, 20, 21, 29) . PtdOH can then act as an intracellular Ca2' ionophore (32) and, thus, cause further release of Ca2' from the dense tubular system (38) .
Our results on the increased incorporation of 32P into polyphosphoinositides, subsequent to their initial loss, are in agreement with those recently published (17) . This response also is shared by a variety of platelet agonists such as thrombin, collagen, and ADP (25, 39) , and it appears [contrarily to the initial loss of PtdIns(4,5)P2] to be a consequence of increased intracellular Ca2+ concentrations. This response is also provoked by ionophore A23187 (25) and is inhibited when the increase in cytosolic Ca2+ concentration is prevented by prostacyclin (Fig. 3) . The increased formation of polyphosphoinositides can bind divalent cations (26) (27) (28) and might enhance the efficiency of the Ca2+ pump (33) . The resultant decrease in cytosolic levels of Ca2+ can then limit both the degradation of membrane components and the degree of cellular activation. An alternative role for the increased formation of polyphosphoinositides is suggested by a recent study (40) showing that increased incorporation of PtdIns(4,5)P2 into the erythrocyte ghost membrane causes increased lateral mobility of erythrocyte glycoprotein. It might well be that the increased formation of PtdIns(4,5)P2 in stimulated platelets is associated with similar specific changes in the platelet membrane.
